摘要
目的研究生长抑素联合香丹注射液治疗急性胰腺炎疗效,为临床治疗提供参考依据。方法抽取我院急性胰腺炎患者62例,进行分组研究。按照随机分组原则,分为联合组和单用组,每组31例。联合组采用生长抑素联合香丹注射液治疗,单用组采用生长抑素治疗。对比效果。结果联合组治愈率高于单用组,差异有统计学意义(P<0.05);联合组并发症发生率跟单用组无显著差异(P>0.05)。联合组患者APACHE-Ⅱ、血淀粉酶、WBC和白蛋白改善优于单用组,差异有统计学意义(P<0.05)。结论生长抑素联合香丹注射液治疗急性胰腺炎疗效显著,跟单用生长抑素对比,治愈率高,实验室指标改善显著,且安全可靠。
ObjectiveTo study the combined somatostatin Xiangdan Injection treatment of acute pancreatitis effect, provide a reference for clinical treatment.Methods62 cases of acute pancreatitis patients, study group. In accordance with the principles of randomized, divided into combined group and alone group, 31 cases in each group. Joint use of somatostatin combined group Xiangdan injection therapy, the use of somatostatin therapy alone group.ResultsThe cure rate was significantly higher than the results of the combined group alone group, the difference was statistically signiifcant (P〈0.05); the combined group with a single complication rate with no signiifcant difference (P〉0.05). The combined group of patients APACHE-Ⅱ, serum amylase, WBC and albumin improved significantly better than single group, the difference was statistically signiifcant (P〈0.05). ConclusionXiangdan injection of somatostatin combined treatment of acute pancreatitis signiifcant effect, with the single somatostatin contrast, high cure rate, a significant improvement in laboratory parameters, and is safe and reliable, worthy of promotion.
出处
《中国继续医学教育》
2015年第12期199-199,共1页
China Continuing Medical Education
关键词
生长抑素
香丹注射液
急性胰腺炎
Somatostatin
Xiangdan injection
Acute pancreatitis